Voleon Capital Management’s Gilead Sciences GILD Stock Holding History

Voleon Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.91M	Buy	23,049 +17,920	+349%	+$2.36M	0.05%	294
2026 Q1	$715K	Buy	5,129 +2,941	+134%	+$412K	0.02%	504
2025 Q4	$269K	Sell	2,188 -14,836	-87%	-$1.8M	0.01%	682
2025 Q3	$1.89M	Sell	17,024 -4,962	-23%	-$564K	0.05%	321
2025 Q2	$2.44M	Sell	21,986 -348	-2%	-$37K	0.13%	155
2025 Q1	$2.5M	Sell	22,334 -34,020	-60%	-$3.51M	0.2%	119
2024 Q4	$5.21M	Buy	+56,354	New	+$5.07M	0.39%	74
2021 Q1	–	Sell	-75,000	Closed	-$4.37M	–	14
2020 Q4	$4.37M	Buy	+75,000	New	+$4.53M	0.47%	39
2019 Q1	–	Sell	-350,000	Closed	-$21.9M	–	37
2018 Q4	$21.9M	Buy	+350,000	New	+$24.5M	2.09%	19

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Voleon Capital Management's GILD Position: Q2 2026 in Review

Voleon Capital Management increased its Gilead Sciences (GILD) stake by 349% in Q2 2026, buying an estimated $2.36M and bringing the position to 23,049 shares worth $2.91M. The position accounts for 0.05% of the portfolio, ranked #294.

Voleon Capital Management first reported a position in GILD in Q4 2018 and has held it in 9 quarters since. The position peaked at $21.9M in Q4 2018. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Voleon Capital Management held 23,049 shares of Gilead Sciences worth $2.91M as of Q2 2026.
Voleon Capital Management bought 17,920 Gilead Sciences shares in Q2 2026, an estimated $2.36M.
Gilead Sciences made up 0.05% of Voleon Capital Management's portfolio in Q2 2026, its #294 holding.
Voleon Capital Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 9 quarters since.
Voleon Capital Management's Gilead Sciences position peaked at $21.9M in Q4 2018.
2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.